Novartis’ Pluvicto Wins FDA Approval for Earlier Prostate Cancer Treatment
SILVER SPRING, Md., July 31, 2026 The U.S. Food and Drug Administration (FDA) has approved Novartis’ Pluvicto (lutetium Lu...
metastatic prostate cancer
Advertisement
Pfizer Inc. Wins FDA Priority Review for Prostate Cancer Therapy
NEW YORK, July 22, 2026 Pfizer Inc. announced that the U.S. Food and Drug Administration (FDA) has granted Priority...
Skyhawk Therapeutics Advances Global Phase 2/3 HD Trial
BOSTON, Mass. — July 14, 2026 Skyhawk Therapeutics, Inc. has announced a major expansion of its global pivotal Phase...
Caris Life Sciences Expands PTEN Testing for Prostate Cancer
IRVING, Texas — July 14, 2026 Caris Life Sciences has expanded its precision oncology portfolio with the launch of...
Veracyte Highlights Practice-Changing Cancer Test Data at ASCO 2026
SOUTH SAN FRANCISCO, California, 21 May 2026 Veracyte, Inc. announced that major Phase III clinical trial results involving its...
Advertisement
